Nucleai Company
Nucleai is a company that uses AI technology to improve drug development and patient outcomes in the field of spatial biology. They have a platform that utilizes tissue datasets to gain insights into cancer biology, which can increase the effectiveness of clinical trials and improve patient care. Nucleai collaborates with top pharmaceutical companies and licenses its research platform for internal use, as well as working on biomarker discovery projects.
Founded Date:
2017
Technology:
Machine Learning
Funding Status:
Early Stage Venture
Total Funding:
46500000
Employee Number:
11-50
Headquarters:
Tel Aviv, Tel Aviv, Israel
Last Funding Date:
2022-03-22
Investors Number:
7
Last Funding Type:
Series B
Estimated Revenue:
$1M to $10M
Industry:
General Healthcare